About | HeinOnline Law Journal Library | HeinOnline Law Journal Library | HeinOnline



1 [1] (January 25, 2021)

handle is hein.crs/goveblu0001 and id is 1 raw text is: 




       ressionai Sos eswh $ervh~e
hdosnPng the Ie~i.4~it4v dot ati~ srne 1q14


January 25, 2021


The Army's Armored Multi-Purpose Vehicle (AMPV)


Background
The Army  describes the Armored Multi-Purpose Vehicle
(AMPV),  a tracked support vehicle, as follows:
    The Armored  Multi-Purpose Vehicle (AMPV)  is
    the replacement for the M113 Family of Vehicles
    (FoV) within the Armored Brigade Combat Team
    (ABCT),  comprising approximately 30%  of its
    tracked vehicle fleet. There are five variants:
    The   General  Purpose   (Figure  1)  variant
    accommodates   two  crew,  six passengers, is
    reconfigurable to carry one litter, mount crew
    served weapons,  and  integrates a variety of
    communications andbattle management systems.
    The Mortar  Carrier variant accommodates two
    crew members,  two mortar crew  members, one
    mounted  120 mm  mortar, 69 rounds of 120 mm
    ammunition, and communications and fire control
    systems.
    The Mission Command   variant is the corneistone
    of the Army's  ABCT Network Modernization
    Strategy. It is intended to take advantage of
    increased  size, weight, power   and  cooling
    technology and provide a significant increase in
    command,  control, communications and conputer
    capability. The variant accommodates a driver and
    commander  and two workstation operators, and its
    red side network provides full Tactical Command
    Post capabilities at brigade and battalion levels.
    The Medical Evacuation variant includes roomfor
    three crew members, sixambulatory patients or four
    litter patients or three ambulatory and two litter
    patients, and storage for medical equipment.
    The Medical Treatment variant includes roomfor
    four crew members, one litter patient and a patient
    treatment table.


Figure I. The Armored  Multi-Purpose Vehicle
(AM PVI  Gene ral Puroose Variant


Source: United States Army Acquisition Support Center,
https://asc.army.mil/web/portfolio-item/gcs-ampv/, accessed January
18, 2021.
Current Program Status
The AMPVis   currently being producedby BAE Systems in
York, PA. On January 25, 2019, the AMPVenteredthe
low-rate initial productionphase. The Army planned for
acquiring a totalof2,907 AMPVs, with initial vehicle
delivery in 2020. The current AMPVprogramplans to
replace 2,897 M 113 vehicles at the brigade and below level
within the ABCT. There are an additional 1,922 M113s
supporting non-ABCT  affiliated units (referred to as
Echelons Above Brigade [EAB] units) that are notincluded
in the Army's modernization plan. A full-rate production
(FRP) decision is planned for the third quarter of FY2022.


Low-Rate   Initial Production (LRIP) is a programmatic
decision made when manufacturing development is completed
and  there is an ability to produce a snmll-quantity set of
articles. It also establishes an initial production base and sets
the  stage for a gradual increase in the production rate to
allow for Full-Rate Production (FRP) upon completion of
Operational Test and Evaluation (OT&E).
Full-Rate Production (FRP) is a decision made that allows
for government contrctingfor economic production
quantities following stabilization of the system design and
validation of the production process.


               Testing  Deficiencies and Production Problems
               During a limited user test(LUT)in FY2019, the
               Department of Defense (DOD) Director of Operational Test
               and Evaluation(DOT&E)  and the Army Testand
               Evaluation Command  (ATEC)identified 24 items while
               testing prototype AMPVs that BAE should correct and have
               ev aluated during the Initial Operational Test and Ev aluation
               (IOT&E)  planned for the fourth quarter of FY2021.
               Reportedly due to BAEproduction challenges and effects
https://crs reports.congress.gov


------------------------------------- - ----------- - ------------------ -------------------------------------------